.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
In a major regulatory development, the Competition Commission of India (CCI) recently dismissed antitrust allegations against 12 super-specialty hospitals. Consequently, the CCI closes hospital probe that spanned over ten years in Delhi. Specifically, the regulator rejected the Director General’s (DG) findings of overpricing. Those findings previously accused these private healthcare facilities of abusing their dominant market position.
The DG had alleged that the hospitals engaged in unfair pricing. For example, the investigation focused on diagnostic tests, medical consumables, and room tariffs. However, the Commission disagreed with this narrow market definition. It ruled that hospital services are bundled packages. Therefore, patients seek integrated treatment rather than individual commodities.
Furthermore, the watchdog compared hospital services with standalone facilities. It noted that hospital rooms require clinical equipment. Thus, these rooms are not comparable to standard hotel accommodations. Similarly, hospital labs operate continuously to provide urgent diagnostic care. As a result, they incur higher operational costs than standalone labs.
Under Section 4 of the Competition Act, excessive pricing alone is not illegal. Instead, the law requires proof of unfairness. To determine this, the CCI applied the two-stage test from the United Brands case. This test requires establishing both an excessive limb and an unfair limb.
However, the DG failed to prove both requirements. The regulatory body observed that charging higher prices does not automatically mean abuse of dominance. In addition, hospitals are allowed to sell items within the Maximum Retail Price (MRP). Consequently, the Commission closed the proceedings and cleared all 12 hospitals of the charges.
Q1: Why did the CCI dismiss the overpricing allegations against the 12 Delhi hospitals?
The CCI dismissed the allegations because the evidence failed to prove abuse of dominance or unfair pricing. Additionally, the regulator emphasized that patients seek bundled healthcare services rather than isolated products.
Q2: What is the United Brands test used by the Commission?
The United Brands standard is a two-stage legal test. Specifically, it requires proving that a price is both excessive and unfair in itself before ruling it as an abuse of dominance.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
The CCI has dismissed the abuse of dominance allegations against 12 private Delhi hospitals, rejecting the Director General's pricing investigation findings...
2 months ago
Andhra Pradesh reported 10 new Covid-19 cases, taking the state tally to 49 while deaths remain at four. With 24 patients hospitalized and 16 under home isolation, the Health Department has intensified monitoring. Medical professionals should review regional distribution, diagnostic protocols, and management plans.
Today
An 11-year Swedish registry study of 618 uterine sarcoma patients found that minimally invasive surgery yielded survival comparable to open surgery in early stages. However, adjuvant chemotherapy conferred no survival benefit in localized or advanced disease, highlighting stage and histology as key outcomes.
3 days back
A cross-sectional study evaluates post-intensive care syndrome in cardiac patients 2-4 weeks post-ICU discharge, highlighting cognitive, psychological, and functional impairments and the need for structured multidisciplinary rehabilitation.
3 days back
Anterior cruciate ligament reconstruction failure lacks uniform definition. A narrative review proposes an integrative framework incorporating objective and subjective instability, persistent pain, restricted motion, graft rupture, and secondary meniscal injury to standardize clinical reporting.
3 days back
With World Obesity Atlas data warning that over 41 million Indian children are overweight or obese, ICMR and NIN have unveiled a 10-point policy roadmap. The initiative calls for mandatory front-of-pack labeling, HFSS taxes, strict marketing bans, and healthier school environments to curb non-communicable diseases.
Today
